Phase 1 clinical study of cyclophilin B peptide vaccine for patients with lung cancer.
Gohara R, Imai N, Rikimaru T, Yamada A, Hida N, Ichiki M, Kawamoto M, Matsunaga K, Ashihara J, Yano S, Tamura M, Ohkouchi S, Yamana H, Oizumi K, Itoh K.
Gohara R, et al. Among authors: yamada a.
J Immunother. 2002 Sep-Oct;25(5):439-44. doi: 10.1097/00002371-200209000-00008.
J Immunother. 2002.
PMID: 12218782
Clinical Trial.